메뉴 건너뛰기




Volumn 12, Issue 6, 2012, Pages 476-483

Nucleotide excision repair gene variants and association with survival in osteosarcoma patients treated with neoadjuvant chemotherapy

Author keywords

DNA repair; event free survival; nucleotide excision repair; osteosarcoma; polymorphism

Indexed keywords

CISPLATIN; DOXORUBICIN; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 5; IFOSFAMIDE; METHOTREXATE; TUMOR MARKER; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 84870055970     PISSN: 1470269X     EISSN: 14731150     Source Type: Journal    
DOI: 10.1038/tpj.2011.33     Document Type: Article
Times cited : (60)

References (55)
  • 3
    • 77953149377 scopus 로고    scopus 로고
    • Use of chemotherapy for patients with bone and soft-tissue sarcomas
    • Wesolowski R, Budd GT. Use of chemotherapy for patients with bone and soft-tissue sarcomas. Cleve Clin J Med 2010; 77(Suppl 1): S23-S26.
    • (2010) Cleve Clin J Med , vol.77 , Issue.SUPPL. 1
    • Wesolowski, R.1    Budd, G.T.2
  • 4
    • 28244477646 scopus 로고    scopus 로고
    • Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy
    • Bacci G, Longhi A, Fagioli F, Briccoli A, Versari M, Picci P. Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy. Eur J Cancer 2005; 41: 2836-2845.
    • (2005) Eur J Cancer , vol.41 , pp. 2836-2845
    • Bacci, G.1    Longhi, A.2    Fagioli, F.3    Briccoli, A.4    Versari, M.5    Picci, P.6
  • 5
    • 3543035771 scopus 로고    scopus 로고
    • Biology and therapeutic advances for pediatric osteosarcoma
    • Marina N, Gebhardt M, Teot L, Gorlick R. Biology and therapeutic advances for pediatric osteosarcoma. Oncologist 2004; 9: 422-441.
    • (2004) Oncologist , vol.9 , pp. 422-441
    • Marina, N.1    Gebhardt, M.2    Teot, L.3    Gorlick, R.4
  • 6
    • 33644505791 scopus 로고    scopus 로고
    • Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution
    • Bacci G, Longhi A, Versari M, Mercuri M, Briccoli A, Picci P. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer 2006; 106: 1154-1161.
    • (2006) Cancer , vol.106 , pp. 1154-1161
    • Bacci, G.1    Longhi, A.2    Versari, M.3    Mercuri, M.4    Briccoli, A.5    Picci, P.6
  • 7
    • 38649098169 scopus 로고    scopus 로고
    • A review of clinical and molecular prognostic factors in osteosarcoma
    • Clark JC, Dass CR, Choong PF. A review of clinical and molecular prognostic factors in osteosarcoma. J Cancer Res Clin Oncol 2008; 134: 281-297.
    • (2008) J Cancer Res Clin Oncol , vol.134 , pp. 281-297
    • Clark, J.C.1    Dass, C.R.2    Choong, P.F.3
  • 8
    • 0037317566 scopus 로고    scopus 로고
    • Value of P-glycoprotein and clinicopathologic factors as the basis for new treatment strategies in high-grade osteosarcoma of the extremities
    • Serra M, Scotlandi K, Reverter-Branchat G, Ferrari S, Manara MC, Benini S et al. Value of P-glycoprotein and clinicopathologic factors as the basis for new treatment strategies in high-grade osteosarcoma of the extremities. J Clin Oncol 2003; 21: 536-542.
    • (2003) J Clin Oncol , vol.21 , pp. 536-542
    • Serra, M.1    Scotlandi, K.2    Reverter-Branchat, G.3    Ferrari, S.4    Manara, M.C.5    Benini, S.6
  • 10
    • 33747463577 scopus 로고    scopus 로고
    • Genetic polymorphisms of the XPG and XPD nucleotide excision repair genes in sarcoma patients
    • Le MV, Longy M, Bonaiti-Pellie C, Bui B, Houede N, Coindre JM et al. Genetic polymorphisms of the XPG and XPD nucleotide excision repair genes in sarcoma patients. Int J Cancer 2006; 119: 1732-1735.
    • (2006) Int J Cancer , vol.119 , pp. 1732-1735
    • Le, M.V.1    Longy, M.2    Bonaiti-Pellie, C.3    Bui, B.4    Houede, N.5    Coindre, J.M.6
  • 12
    • 77955744323 scopus 로고    scopus 로고
    • Genomic alterations and allelic imbalances are strong prognostic predictors in osteosarcoma
    • Smida J, Baumhoer D, Rosemann M, Walch A, Bielack S, Poremba C et al. Genomic alterations and allelic imbalances are strong prognostic predictors in osteosarcoma. Clin Cancer Res 2010; 16: 4256-4267.
    • (2010) Clin Cancer Res , vol.16 , pp. 4256-4267
    • Smida, J.1    Baumhoer, D.2    Rosemann, M.3    Walch, A.4    Bielack, S.5    Poremba, C.6
  • 13
  • 14
    • 40949130371 scopus 로고    scopus 로고
    • Platinum resistance: The role of DNA repair pathways
    • Martin LP, Hamilton TC, Schilder RJ. Platinum resistance: the role of DNA repair pathways. Clin Cancer Res 2008; 14: 1291-1295.
    • (2008) Clin Cancer Res , vol.14 , pp. 1291-1295
    • Martin, L.P.1    Hamilton, T.C.2    Schilder, R.J.3
  • 15
    • 0031791029 scopus 로고    scopus 로고
    • Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy
    • Reed E. Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy. Cancer Treat Rev 1998; 24: 331-344.
    • (1998) Cancer Treat Rev , vol.24 , pp. 331-344
    • Reed, E.1
  • 16
    • 3843130823 scopus 로고    scopus 로고
    • A multivariate analysis of genomic polymorphisms: Prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer
    • Stoehlmacher J, Park DJ, Zhang W, Yang D, Groshen S, Zahedy S et al. A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer. Br J Cancer 2004; 91: 344-354.
    • (2004) Br J Cancer , vol.91 , pp. 344-354
    • Stoehlmacher, J.1    Park, D.J.2    Zhang, W.3    Yang, D.4    Groshen, S.5    Zahedy, S.6
  • 17
    • 11144245523 scopus 로고    scopus 로고
    • ERCC2/XPD gene polymorphisms and lung cancer: A HuGE review
    • Benhamou S, Sarasin A. ERCC2/XPD gene polymorphisms and lung cancer: a HuGE review. Am J Epidemiol 2005; 161: 1-14.
    • (2005) Am J Epidemiol , vol.161 , pp. 1-14
    • Benhamou, S.1    Sarasin, A.2
  • 18
    • 0034098801 scopus 로고    scopus 로고
    • Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells
    • Duell EJ, Wiencke JK, Cheng TJ, Varkonyi A, Zuo ZF, Ashok TD et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis 2000; 21: 965-971.
    • (2000) Carcinogenesis , vol.21 , pp. 965-971
    • Duell, E.J.1    Wiencke, J.K.2    Cheng, T.J.3    Varkonyi, A.4    Zuo, Z.F.5    Ashok, T.D.6
  • 20
    • 0035866403 scopus 로고    scopus 로고
    • Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients
    • Spitz MR, Wu X, Wang Y, Wang LE, Shete S, Amos CI et al. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res 2001; 61: 1354-1357.
    • (2001) Cancer Res , vol.61 , pp. 1354-1357
    • Spitz, M.R.1    Wu, X.2    Wang, Y.3    Wang, L.E.4    Shete, S.5    Amos, C.I.6
  • 21
    • 70349678400 scopus 로고    scopus 로고
    • Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients
    • Caronia D, Patino-Garcia A, Milne RL, Zalacain-Diez M, Pita G, Alonso MR et al. Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients. Pharmacogenomics J 2009; 9: 347-353.
    • (2009) Pharmacogenomics J , vol.9 , pp. 347-353
    • Caronia, D.1    Patino-Garcia, A.2    Milne, R.L.3    Zalacain-Diez, M.4    Pita, G.5    Alonso, M.R.6
  • 22
    • 33645298447 scopus 로고    scopus 로고
    • Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients
    • De las Penas R, Sanchez-Ronco M, Alberola V, Taron M, Camps C, Garcia-Carbonero R et al. Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients. Ann Oncol 2006; 17: 668-675.
    • (2006) Ann Oncol , vol.17 , pp. 668-675
    • De Las Penas, R.1    Sanchez-Ronco, M.2    Alberola, V.3    Taron, M.4    Camps, C.5    Garcia-Carbonero, R.6
  • 23
    • 4344567395 scopus 로고    scopus 로고
    • XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced nonsmall-cell lung cancer patients treated with platinum chemotherapy
    • Gurubhagavatula S, Liu G, Park S, Zhou W, Su L, Wain JC et al. XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced nonsmall-cell lung cancer patients treated with platinum chemotherapy. J Clin Oncol 2004; 22: 2594-2601.
    • (2004) J Clin Oncol , vol.22 , pp. 2594-2601
    • Gurubhagavatula, S.1    Liu, G.2    Park, S.3    Zhou, W.4    Su, L.5    Wain, J.C.6
  • 24
    • 63749117523 scopus 로고    scopus 로고
    • Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: A Korean population-based study
    • Kim HS, Kim MK, Chung HH, Kim JW, Park NH, Song YS et al. Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: a Korean population-based study. Gynecol Oncol 2009; 113: 264-269.
    • (2009) Gynecol Oncol , vol.113 , pp. 264-269
    • Kim, H.S.1    Kim, M.K.2    Chung, H.H.3    Kim, J.W.4    Park, N.H.5    Song, Y.S.6
  • 25
    • 49049118079 scopus 로고    scopus 로고
    • Relationship between ERCC1 polymorphisms, disease progression, and survival in the Gynecologic Oncology Group Phase III Trial of intraperitoneal versus intravenous cisplatin and paclitaxel for stage III epithelial ovarian cancer
    • Krivak TC, Darcy KM, Tian C, Armstrong D, Baysal BE, Gallion H et al. Relationship between ERCC1 polymorphisms, disease progression, and survival in the Gynecologic Oncology Group Phase III Trial of intraperitoneal versus intravenous cisplatin and paclitaxel for stage III epithelial ovarian cancer. J Clin Oncol 2008; 26: 3598-3606.
    • (2008) J Clin Oncol , vol.26 , pp. 3598-3606
    • Krivak, T.C.1    Darcy, K.M.2    Tian, C.3    Armstrong, D.4    Baysal, B.E.5    Gallion, H.6
  • 26
    • 33749036570 scopus 로고    scopus 로고
    • DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy
    • Quintela-Fandino M, Hitt R, Medina PP, Gamarra S, Manso L, Cortes-Funes H et al. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy. J Clin Oncol 2006; 24: 4333-4339.
    • (2006) J Clin Oncol , vol.24 , pp. 4333-4339
    • Quintela-Fandino, M.1    Hitt, R.2    Medina, P.P.3    Gamarra, S.4    Manso, L.5    Cortes-Funes, H.6
  • 27
    • 0041766793 scopus 로고    scopus 로고
    • Nucleotide excision repair pathways involved in cisplatin resistance in non-smallcell lung cancer
    • Rosell R, Taron M, Barnadas A, Scagliotti G, Sarries C, Roig B. Nucleotide excision repair pathways involved in cisplatin resistance in non-smallcell lung cancer. Cancer Control 2003; 10: 297-305.
    • (2003) Cancer Control , vol.10 , pp. 297-305
    • Rosell, R.1    Taron, M.2    Barnadas, A.3    Scagliotti, G.4    Sarries, C.5    Roig, B.6
  • 28
    • 33748324572 scopus 로고    scopus 로고
    • Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy
    • Sakano S, Wada T, Matsumoto H, Sugiyama S, Inoue R, Eguchi S et al. Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy. Br J Cancer 2006; 95: 561-570.
    • (2006) Br J Cancer , vol.95 , pp. 561-570
    • Sakano, S.1    Wada, T.2    Matsumoto, H.3    Sugiyama, S.4    Inoue, R.5    Eguchi, S.6
  • 29
    • 34748913817 scopus 로고    scopus 로고
    • Nucleotide excision repair pathway review I: Implications in ovarian cancer and platinum sensitivity
    • Saldivar JS, Wu X, Follen M, Gershenson D. Nucleotide excision repair pathway review I: implications in ovarian cancer and platinum sensitivity. Gynecol Oncol 2007; 107(Suppl 1): S56-S71.
    • (2007) Gynecol Oncol , vol.107 , Issue.SUPPL. 1
    • Saldivar, J.S.1    Wu, X.2    Follen, M.3    Gershenson, D.4
  • 30
    • 68849129048 scopus 로고    scopus 로고
    • Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes
    • Bradbury PA, Kulke MH, Rebecca SH, Zhou W, Ma C, Xu W et al. Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes. Pharmacogenet Genomics 2009; 19: 613-625.
    • (2009) Pharmacogenet Genomics , vol.19 , pp. 613-625
    • Bradbury, P.A.1    Kulke, M.H.2    Rebecca, S.H.3    Zhou, W.4    Ma, C.5    Xu, W.6
  • 31
    • 0036247508 scopus 로고    scopus 로고
    • The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk
    • Hou SM, Falt S, Angelini S, Yang K, Nyberg F, Lambert B et al. The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis 2002; 23: 599-603.
    • (2002) Carcinogenesis , vol.23 , pp. 599-603
    • Hou, S.M.1    Falt, S.2    Angelini, S.3    Yang, K.4    Nyberg, F.5    Lambert, B.6
  • 32
    • 33846923410 scopus 로고    scopus 로고
    • Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: A meta-analysis
    • Kiyohara C, Yoshimasu K. Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis. Int J Med Sci 2007; 4: 59-71.
    • (2007) Int J Med Sci , vol.4 , pp. 59-71
    • Kiyohara, C.1    Yoshimasu, K.2
  • 34
    • 19944428647 scopus 로고    scopus 로고
    • Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk
    • Terry MB, Gammon MD, Zhang FF, Eng SM, Sagiv SK, Paykin AB et al. Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2004; 13: 2053-2058.
    • (2004) Cancer Epidemiol Biomarkers Prev , vol.13 , pp. 2053-2058
    • Terry, M.B.1    Gammon, M.D.2    Zhang, F.F.3    Eng, S.M.4    Sagiv, S.K.5    Paykin, A.B.6
  • 35
    • 0034980986 scopus 로고    scopus 로고
    • Polymorphisms of the DNA repair gene XPD: Correlations with risk of basal cell carcinoma revisited
    • Vogel U, Hedayati M, Dybdahl M, Grossman L, Nexo BA. Polymorphisms of the DNA repair gene XPD: correlations with risk of basal cell carcinoma revisited. Carcinogenesis 2001; 22: 899-904.
    • (2001) Carcinogenesis , vol.22 , pp. 899-904
    • Vogel, U.1    Hedayati, M.2    Dybdahl, M.3    Grossman, L.4    Nexo, B.A.5
  • 36
    • 9144230618 scopus 로고    scopus 로고
    • Two regions in chromosome 19q13.2-3 are associated with risk of lung cancer
    • Vogel U, Laros I, Jacobsen NR, Thomsen BL, Bak H, Olsen A et al. Two regions in chromosome 19q13.2-3 are associated with risk of lung cancer. Mutat Res 2004; 546: 65-74.
    • (2004) Mutat Res , vol.546 , pp. 65-74
    • Vogel, U.1    Laros, I.2    Jacobsen, N.R.3    Thomsen, B.L.4    Bak, H.5    Olsen, A.6
  • 37
    • 77954563856 scopus 로고    scopus 로고
    • Population study of genetic polymorphisms and superficial bladder cancer risk in Han-Chinese smokers in Shanghai
    • Wen H, Ding Q, Fang ZJ, Xia GW, Fang J. Population study of genetic polymorphisms and superficial bladder cancer risk in Han-Chinese smokers in Shanghai. Int Urol Nephrol 2009; 41: 855-864.
    • (2009) Int Urol Nephrol , vol.41 , pp. 855-864
    • Wen, H.1    Ding, Q.2    Fang, Z.J.3    Xia, G.W.4    Fang, J.5
  • 38
    • 4644245336 scopus 로고    scopus 로고
    • Polymorphisms in the DNA repair gene XPD and susceptibility to esophageal squamous cell carcinoma
    • Yu HP, Wang XL, Sun X, Su YH, Wang YJ, Lu B et al. Polymorphisms in the DNA repair gene XPD and susceptibility to esophageal squamous cell carcinoma. Cancer Genet Cytogenet 2004; 154: 10-15.
    • (2004) Cancer Genet Cytogenet , vol.154 , pp. 10-15
    • Yu, H.P.1    Wang, X.L.2    Sun, X.3    Su, Y.H.4    Wang, Y.J.5    Lu, B.6
  • 39
    • 13944275920 scopus 로고    scopus 로고
    • Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer
    • Zhou W, Liu G, Park S, Wang Z, Wain JC, Lynch TJ et al. Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 491-496.
    • (2005) Cancer Epidemiol Biomarkers Prev , vol.14 , pp. 491-496
    • Zhou, W.1    Liu, G.2    Park, S.3    Wang, Z.4    Wain, J.C.5    Lynch, T.J.6
  • 40
    • 42149190878 scopus 로고    scopus 로고
    • Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma
    • Doecke J, Zhao ZZ, Pandeya N, Sadeghi S, Stark M, Green AC et al. Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma. Int J Cancer 2008; 123: 174-180.
    • (2008) Int J Cancer , vol.123 , pp. 174-180
    • Doecke, J.1    Zhao, Z.Z.2    Pandeya, N.3    Sadeghi, S.4    Stark, M.5    Green, A.C.6
  • 42
    • 33845382806 scopus 로고
    • Non-parametric estimation from incomplete observations
    • Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
    • (1958) J Am Stat Assoc , vol.53 , pp. 457-481
    • Kaplan, E.L.1    Meier, P.2
  • 43
    • 0000336139 scopus 로고
    • Regression models and life tables
    • Cox DR. Regression models and life tables. J Roy Stat Soc B 1972; 34: 187-220.
    • (1972) J Roy Stat Soc B , vol.34 , pp. 187-220
    • Cox, D.R.1
  • 45
    • 77953669219 scopus 로고    scopus 로고
    • The epidemiology of osteosarcoma
    • Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res 2009; 152: 3-13.
    • (2009) Cancer Treat Res , vol.152 , pp. 3-13
    • Ottaviani, G.1    Jaffe, N.2
  • 46
    • 38949208772 scopus 로고    scopus 로고
    • Association of a missense single nucleotide polymorphism, Cys1367Arg of the WRN gene, with the risk of bone and soft tissue sarcomas in Japan
    • Nakayama R, Sato Y, Masutani M, Ogino H, Nakatani F, Chuman H et al. Association of a missense single nucleotide polymorphism, Cys1367Arg of the WRN gene, with the risk of bone and soft tissue sarcomas in Japan. Cancer Sci 2008; 99: 333-339.
    • (2008) Cancer Sci , vol.99 , pp. 333-339
    • Nakayama, R.1    Sato, Y.2    Masutani, M.3    Ogino, H.4    Nakatani, F.5    Chuman, H.6
  • 47
    • 58149087457 scopus 로고    scopus 로고
    • Susceptibility of XRCC3 XPD, and XPG genetic variants to cervical carcinoma
    • He X, Ye F, Zhang J, Cheng Q, Shen J, Chen H. Susceptibility of XRCC3, XPD, and XPG genetic variants to cervical carcinoma. Pathobiology 2008; 75: 356-363.
    • (2008) Pathobiology , vol.75 , pp. 356-363
    • He, X.1    Ye, F.2    Zhang, J.3    Cheng, Q.4    Shen, J.5    Chen, H.6
  • 48
    • 77955776374 scopus 로고    scopus 로고
    • Associations between XPD polymorphisms and risk of breast cancer: A meta-analysis
    • Jiang Z, Li C, Xu Y, Cai S, Wang X. Associations between XPD polymorphisms and risk of breast cancer: a meta-analysis. Breast Cancer Res Treat 2010; 123: 203-212.
    • (2010) Breast Cancer Res Treat , vol.123 , pp. 203-212
    • Jiang, Z.1    Li, C.2    Xu, Y.3    Cai, S.4    Wang, X.5
  • 49
    • 41549142137 scopus 로고    scopus 로고
    • DNA repair gene XPD polymorphisms and cancer risk: A meta-analysis based on 56 case-control studies
    • Wang F, Chang D, Hu FL, Sui H, Han B, Li DD et al. DNA repair gene XPD polymorphisms and cancer risk: a meta-analysis based on 56 case-control studies. Cancer Epidemiol Biomarkers Prev 2008; 17: 507-517.
    • (2008) Cancer Epidemiol Biomarkers Prev , vol.17 , pp. 507-517
    • Wang, F.1    Chang, D.2    Hu, F.L.3    Sui, H.4    Han, B.5    Li, D.D.6
  • 50
    • 80052500516 scopus 로고    scopus 로고
    • The association between XPD Asp312Asn polymorphism and lung cancer risk: A meta-analysis including 16949 subjects
    • published online 30 November 2010 doi:10.1007/s12032-010-9501-8 [e-pub ahead of print]
    • Zhang J, Qiu LX, Leaw SJ, Hu XC, Chang JH. The association between XPD Asp312Asn polymorphism and lung cancer risk: a meta-analysis including 16,949 subjects. Med Oncol; published online 30 November 2010; doi:10.1007/s12032-010- 9501-8 [e-pub ahead of print].
    • Med Oncol
    • Zhang, J.1    Qiu, L.X.2    Leaw, S.J.3    Hu, X.C.4    Chang, J.H.5
  • 51
    • 85044709822 scopus 로고    scopus 로고
    • Correlation of XPD gene with susceptibility to gastric cancer
    • Zhang CZ, Chen ZP, Xu CQ, Ning T, Li DP, Hou RP. Correlation of XPD gene with susceptibility to gastric cancer. Ai Zheng 2009; 28: 1163-1167.
    • (2009) Ai Zheng , vol.28 , pp. 1163-1167
    • Zhang, C.Z.1    Chen, Z.P.2    Xu, C.Q.3    Ning, T.4    Li, D.P.5    Hou, R.P.6
  • 53
    • 77958034604 scopus 로고    scopus 로고
    • Genome-wide association studies of cancer: Principles and potential utility
    • Stadler ZK, Gallagher DJ, Thom P, Offit K. Genome-wide association studies of cancer: principles and potential utility. Oncology 2010; 24: 629-637.
    • (2010) Oncology , vol.24 , pp. 629-637
    • Stadler, Z.K.1    Gallagher, D.J.2    Thom, P.3    Offit, K.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.